investigated PD-L1 (scored positive if tumors showed ≥1% membranous staining) and CD8 expression (scored for intra-tumor T-cells and stromal cells) in advanced LCNEC, showing PD-L1 positivity in 16% of tumor samples. The gene discussed is CD8A; the disease is neoplasm.